These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 1480101)

  • 1. Fluorogenic peptide substrates optimized for five human matrix metalloproteinases.
    Angleton EL; Nagase H; Birkedal-Hansen H; Van Wart HE
    Matrix Suppl; 1992; 1():89-90. PubMed ID: 1480101
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative sequence specificities of human fibroblast and neutrophil matrix metalloproteinases.
    Netzel-Arnett SJ; Fields GB; Nagase H; Suzuki K; Moore WG; Birkedal-Hansen H; Van Wart HE
    Matrix Suppl; 1992; 1():74-5. PubMed ID: 1480093
    [No Abstract]   [Full Text] [Related]  

  • 3. New fluorogenic substrates for N-arginine dibasic convertase.
    Csuhai E; Juliano MA; Pyrek JS; Harms AC; Juliano L; Hersh LB
    Anal Biochem; 1999 Apr; 269(1):149-54. PubMed ID: 10094786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assays of matrix metalloproteinases (MMPs) activities: a review.
    Lombard C; Saulnier J; Wallach J
    Biochimie; 2005; 87(3-4):265-72. PubMed ID: 15781313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fluorescent peptide substrate for the surface metalloprotease of Leishmania.
    Bouvier J; Schneider P; Malcolm B
    Exp Parasitol; 1993 Mar; 76(2):146-55. PubMed ID: 8454023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Enzymatic synthesis of peptides of arginine-chromophore substrates of metalloproteinases and carboxypeptidases].
    Iusupova MP; Kotlova EK; Timokhina EA; Stepanov VM
    Bioorg Khim; 1995 Jan; 21(1):33-8. PubMed ID: 7710422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of a fluorogenic interleukin-1 beta converting enzyme substrate based on resonance energy transfer.
    Pennington MW; Thornberry NA
    Pept Res; 1994; 7(2):72-6. PubMed ID: 8012123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The new fluorogenic substrates of neutrophil proteinase 3 optimized in prime site region.
    Wysocka M; Lesner A; Majkowska G; Legowska A; Guzow K; Rolka K; Wiczk W
    Anal Biochem; 2010 Apr; 399(2):196-201. PubMed ID: 20074540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase triple-helical peptidase activities are differentially regulated by substrate stability.
    Minond D; Lauer-Fields JL; Nagase H; Fields GB
    Biochemistry; 2004 Sep; 43(36):11474-81. PubMed ID: 15350133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification of human matrilysin produced in Escherichia coli and characterization using a new optimized fluorogenic peptide substrate.
    Welch AR; Holman CM; Browner MF; Gehring MR; Kan CC; Van Wart HE
    Arch Biochem Biophys; 1995 Dec; 324(1):59-64. PubMed ID: 7503560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorogenic peptide substrates for serine and threonine phosphatases.
    Xue F; Seto CT
    Org Lett; 2010 May; 12(9):1936-9. PubMed ID: 20359238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of proteinase specificity by studies of peptide substrates. The use of UV and fluorescence spectroscopy to quantitate rates of enzymatic cleavage.
    Dunn BM; Scarborough PE; Davenport R; Swietnicki W
    Methods Mol Biol; 1994; 36():225-43. PubMed ID: 7697110
    [No Abstract]   [Full Text] [Related]  

  • 13. Using fluorogenic peptide substrates to assay matrix metalloproteinases.
    Fields GB
    Methods Mol Biol; 2010; 622():393-433. PubMed ID: 20135296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective neurotensin-derived internally quenched fluorogenic substrates for neurolysin (EC 3.4.24.16): comparison with thimet oligopeptidase (EC 3.4.24.15) and neprilysin (EC 3.4.24.11).
    Oliveira V; Campos M; Hemerly JP; Ferro ES; Camargo AC; Juliano MA; Juliano L
    Anal Biochem; 2001 May; 292(2):257-65. PubMed ID: 11355859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorogenic substrates for assay of chymosin.
    Starovoitova VV; Filippova IY; Lysogorskaya EN; Oksenoit ES; Lavrenova GI
    Biochemistry (Mosc); 2000 Jun; 65(6):713-7. PubMed ID: 10887292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic peptides and fluorogenic substrates related to the reactive site sequence of Kunitz-type inhibitors isolated from Bauhinia: interaction with human plasma kallikrein.
    Oliva ML; Santomauro-Vaz EM; Andrade SA; Juliano MA; Pott VJ; Sampaio MU; Sampaio CA
    Biol Chem; 2001 Jan; 382(1):109-13. PubMed ID: 11258660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in substrate and inhibitor sequence specificity of human, mouse and rat tissue kallikreins.
    Fogaça SE; Melo RL; Pimenta DC; Hosoi K; Juliano L; Juliano MA
    Biochem J; 2004 Jun; 380(Pt 3):775-81. PubMed ID: 15040788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuously recording fluorescent assays optimized for five human matrix metalloproteinases.
    Netzel-Arnett S; Mallya SK; Nagase H; Birkedal-Hansen H; Van Wart HE
    Anal Biochem; 1991 May; 195(1):86-92. PubMed ID: 1888020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic characterization of lysine-specific metalloendopeptidases from Grifola frondosa and Pleurotus ostreatus fruiting bodies.
    Nonaka T; Hashimoto Y; Takio K
    J Biochem; 1998 Jul; 124(1):157-62. PubMed ID: 9644258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Tyr605 and Ala607 of thimet oligopeptidase and Tyr606 and Gly608 of neurolysin in substrate hydrolysis and inhibitor binding.
    Machado MF; Rioli V; Dalio FM; Castro LM; Juliano MA; Tersariol IL; Ferro ES; Juliano L; Oliveira V
    Biochem J; 2007 Jun; 404(2):279-88. PubMed ID: 17313369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.